Additionally, intracerebral GM-CSF administration to APP/PS1 mice directly increases blood-brain barrier endothelial permeability, suggesting that high levels of GM-CSF detected in the brain parenchyma and CSF of AD patients may induce blood-brain barrier opening. Here, APP is linked to Alzheimer disease.